Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.
- DOI
- 10.1002/ijc.70588
- Published
- 2026 Oct 15
- Container
- International journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ijc.70588,
title = {Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.},
author = {Hacan BA and Sonugür FG and Öçal M and Babahan C and Abgarmi S and Arslan ÜY and Şendur MA and Demirkazık A and Utkan G and Akbulut H},
year = {2026},
journal = {International journal of cancer},
doi = {10.1002/ijc.70588},
url = {https://doi.org/10.1002/ijc.70588}
}RIS
TY - JOUR TI - Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study. AU - Hacan BA AU - Sonugür FG AU - Öçal M AU - Babahan C AU - Abgarmi S AU - Arslan ÜY AU - Şendur MA AU - Demirkazık A AU - Utkan G AU - Akbulut H PY - 2026 JO - International journal of cancer DO - 10.1002/ijc.70588 UR - https://doi.org/10.1002/ijc.70588 ER -
APA
BA, H., FG, S., M, Ö., C, B., S, A., ÜY, A., MA, Ş., A, D., G, U., & H, A. (2026). Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study.. International journal of cancer. https://doi.org/10.1002/ijc.70588
Source records
- pubmed · retrieved 2026-09-26T19:30:07.143Z